This feature highlights changes in clinical research organizations’ personnel.

Healthix

Healthix has announced that Todd Rogow will lead the organization as its new president and chief executive officer. Rogow previously served as senior vice president and chief information officer at the company.

TRANSEARCH

Larry Glines has joined TRANSEARCH International as managing director for life sciences and healthcare. Glines previously was president of Glines Associates, an executive search firm devoted to the healthcare and life sciences industry, a company he founded in 1995.

Carrick Therapeutics

Carrick Therapeutics has announced the appointment of Tim Pearson as chief executive officer. Pearson previously was executive vice president and chief financial officer for TESARO. Elaine Sullivan will step down as CEO and will continue with the company as executive entrepreneur and advisor to the board of directors, based in Dublin.

Veracyte

Keith Kennedy has been appointed chief operating officer, in conjunction with his current role as chief financial officer, effective immediately, at Veracyte. Prior to joining Veracyte as CFO in 2016, Kennedy served in key executive leadership positions at MCG Capital, Arlington Capital Partners and GE Capital.

Viela Bio

Viela Bio has named Mitchell Chan to the position of chief financial officer. Chan previously served as Viela’s vice president, head of finance and corporate strategy.

Squarex

Jack Talley has been appointed chief executive officer at Squarex. Talley currently serves on the board of Mitotherapeutix and recently served as CEO, president and director of Izun Pharmaceuticals.

Pharmaceutics International

Pharmaceutics International, Inc. (Pii) has announced the expansion of its commercial team. Wayne Ideus has been named senior director, business development; Wayne Grellner has been appointed senior director, business development; and Ryan McFarlane has been named executive director, business management. Ideus was previously key account director with Mallinckrodt Pharmaceuticals. Grellner was most recently director, global business development at Samsung. McFarlane was previously executive director of global marketing operations and global enrollment operations at Accelerated Enrollment Solutions.

Platelet BioGenesis

Sam Rasty has been named president and chief executive officer at Platelet BioGenesis. Rasty was most recently chief operating officer of Homology Medicines, Inc.

Smithers Avanza

Smithers Avanza has appointed Frank Rotella as director of operations. Rotella most recently served as manager of bioanalysis at Syneos Health.

HighTide Therapeutics

HighTide has named Adrian Di Bisceglie as chief medical officer. Di Bisceglie was previously professor of internal medicine and chief of hepatology, division of gastroenterology and hepatology at St. Louis University.

Amplity Health

Pravin Wilfrid has been named chief technology officer at Amplity Health. Wilfrid most recently held roles as CIO/SVP at HTA/Verra Mobility.

Inari Medical

Thomas Tu has been appointed chief medical officer and chief business officer at Inari Medical. Tu is the CEO and president of World Health Initiative and most recently was the director of the cardiac cath lab at Louisville Cardiology.

Royal Philips

Britta Lesaux has been named president and chief executive officer at Philips Canada. Lesaux was formerly the executive director of the health care business group at 3M Canada.

Teckro

Teckro has expanded their leadership team. Brendan Buckley has been appointed chief medical officer; Kelly Brown has been named chief marketing officer; Sandra Blaser has been made vice president of customer success; Anita Callan has been appointed vice president of product; and Neil Flanagan has been named vice president of engineering. Buckley served as chief medical officer and executive vice president of ICON from 2011-2017. Brown was previously vice president of marketing in Europe for Veeva Systems. Blaser established the customer success function for Veeva Systems in Europe. Callan most recently held product and content strategy positions at Aer Lingus. Flanagan was previously head of digital operations at Munich Re.